Randy Brenner
General Counsel at PARATEK PHARMACEUTICALS, INC.
Profile
Randy Brenner is currently the Chief Development & Regulatory Officer at Paratek Pharmaceuticals, Inc. He previously worked at Pfizer Inc. as the Vice President-Established Products Business Units from 2010 to 2011.
He also worked at Shire Plc as the Head-Regulatory Affairs.
Mr. Brenner completed his undergraduate degree at Muhlenberg College and his graduate degree at Temple University School of Pharmacy.
Randy Brenner active positions
Companies | Position | Start |
---|---|---|
PARATEK PHARMACEUTICALS, INC. | General Counsel | 2015-06-02 |
Former positions of Randy Brenner
Companies | Position | End |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 2011-08-31 |
SHIRE | Corporate Officer/Principal | - |
Training of Randy Brenner
Muhlenberg College | Undergraduate Degree |
Temple University School of Pharmacy | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
PFIZER, INC. | Health Technology |
PARATEK PHARMACEUTICALS, INC. | Health Technology |
Private companies | 1 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Randy Brenner